Skip to main content
Day.News — Local News. Real Community.
247 neighbors reading now

Columbus Day News

Terps territory: Education, Innovation, and Community.Columbus, OH Edition
health
5 min read

FDA Releases Results of Infant Formula Contaminant Testing

June 13, 2026

The Food and Drug Administration (FDA) has released the findings of its largest-ever study of chemical contaminants found in infant formula sold across the United States. The agency described the analysis as the most rigorous examination of its kind.

The research scrutinized a wide range of infant formula products available on the U.S. market. Regulators aim to leverage the collected data to inform future policy and regulatory actions concerning infant formula safety.

Specific details regarding the types of contaminants tested for and the levels detected were not immediately disclosed. The FDA indicated further information would be released in the coming days.

Related Topics

Editorial Transparency
AI-Generated · Written by National Desk

Article Ratings

Factual
0.0
Likeable
0.0
Bias
0.0
Objective
0.0

0 ratings submitted

How do you feel about this story?

NA

National Desk

Trust 3.249779 articles1,581,888 views75% fact accuracy
View Profile

Sign in to follow this author from their profile.

Discussion (0)

Join the Conversation

U

Be respectful and thoughtful in your comments.

Sort by:
0 comments

No comments yet. Be the first to comment!

Trending Now

Upcoming Events

Advertisement
Sponsor Message

Related Stories

Weekly Semaglutide Improves Quality of Life for Patients With Diabetes and Kidney Disease

Weekly Semaglutide Improves Quality of Life for Patients With Diabetes and Kidney Disease

Semaglutid improves quality of life for patients with diabetes and kidney disease, study finds

Semaglutid improves quality of life for patients with diabetes and kidney disease, study finds

Semaglutide Study Shows Quality-of-Life Improvements in Diabetic Patients With Kidney Disease

Semaglutide Study Shows Quality-of-Life Improvements in Diabetic Patients With Kidney Disease